No products in the cart.

Anti-Aromatase antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-0372
Anti-Aromatase antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-06-0372
Product type: Primary antibody
Antigen: Aromatase
Immunogen: Peptide
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:400-1:1000); Immunocytochemistry (1:100-1:200); Immunohistochemistry (1:100-1:200); Flow Cytometry (1:40-1:100)
Reactivity: Mouse, Human
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: Tris-HCl buffer (pH7.4), 1% BSA, 50% glycerol, 0.05% NaN3.
Concentration: 1mg/ml
Purity: Protein A/G affinity purified/Antigen affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: ARO antibody
ARO1 antibody
Aromatase antibody
CP19A_HUMAN antibody
CPV1 antibody
CYAR antibody
CYP19 antibody
Cyp19a1 antibody
CYPXIX antibody
Cytochrome P-450AROM antibody
Cytochrome P450 19A1 antibody
Cytochrome P450, Family 19, Subfamily A, Polypeptide 1 antibody
Cytochrome P450, Subfamily XIX (Aromatization of Androgens) antibody
Estrogen Synthase antibody
Estrogen Synthetase antibody
Flavoprotein Linked Monooxygenase antibody
MGC104309 antibody
Microsomal Monooxygenase antibody
OTTHUMP00000162543 antibody
OTTHUMP00000198350 antibody
P450AROM antibody
Show More

Target information

P450 enzymes constitute a family of monooxygenase enzymes that are involved in the metabolism of a wide array of endogenous and xenobiotic compounds. P450 enzymes can be classified, based on their sequence similarities, into distinct subfamilies, which include CYP1A and CYP2A. Other P450 family members include CYP19, also designated aromatase (P450arom), which catalyzes the conversion of C19 steroids to estrogens in various tissues, including placenta, gonads, adipose tissue, skin and brain. CYP19 expression is controlled by hormonally regulated promoters in different tissues and increased CYP19 activity is associated with familial gynecomastia. Also, a polymorphic allele of CYP19 (repeat (TTTA)12) is present in a majority of breast cancer patients. P450 cholesterol 7α-hydroxylase, CYP7A1, is the rate-limiting enzyme of bile acid synthesis in the liver, and its expression is mediated by the bile acid receptor FXR. CYP27A1 catalyzes vitamin D3 25-hydroxylation and is localized to the mitochondria in kidney and liver.

Provider

Erpantech Laboratory

download

MSDS-AB-06-0372.pdf (239 downloads )